SaveSleuth News tracks meaningful developments in CBD, hemp and cannabinoids across major markets. We focus on regulation, court decisions, enforcement, licensing, product safety, recalls, research and market changes that can affect consumers or businesses.
Latest CBD and hemp news
Guernsey introduces 18+ rule for certain CBD products containing THC
Since October 1, certain CBD preparations containing THC have been subject to an 18+ sales restriction across Guernsey, Alderney and Sark.
What we cover
- Regulation and law: new CBD and hemp rules, court decisions, licensing and market-access changes.
- Consumer safety: recalls, contamination alerts, lab findings and official warnings.
- Research and public health: peer-reviewed studies and regulator assessments with clear limits on what the evidence shows.
- Retail and products: changes that affect where products can be sold, who can buy them and how they are classified.
- Market developments: major company or industry moves only when they have clear consumer or regulatory significance.
How SaveSleuth verifies CBD news
We prioritise regulators, courts, government bodies, official company filings or statements, peer-reviewed research and established news organisations. When a primary document is not yet publicly available, we say so rather than filling the gap with assumptions.
CBD reporting often becomes misleading when different product categories or legal systems are treated as interchangeable. A medical cannabis ruling is not automatically a rule for over-the-counter CBD oil, and a US hemp decision does not establish the legal position in Germany, France or the UK.
CBD regulation by product and market
| Topic | What we check |
|---|---|
| CBD oils, gummies and ingestibles | Novel food status, THC limits, labelling, recalls and consumer guidance |
| CBD flowers and hemp products | THC rules, product classification, enforcement and court decisions |
| CBD cosmetics | Ingredient rules, safety assessments and permitted claims |
| Medical cannabinoids | Clinical evidence, medicines regulation and reimbursement without extrapolating to retail CBD |
| International regulation | Jurisdiction-specific rules and whether they have any practical relevance outside that market |
More CBD resources
For background explainers, terminology and product-quality basics, visit the SaveSleuth CBD Wiki. News articles link directly to their underlying sources so readers can review the evidence themselves.
Last updated: October 4, 2026. This section is for general information only and does not constitute medical, legal or regulatory advice.
